Abstracts

Randomized Trial of SEARCH Dynamic Choice HIV Prevention Including Injectable Cabotegravir (CAB-LA)

Background: We hypothesized that an oral PrEP, PEP and CAB-LA biomedical prevention package with structured choice between products and opportunities to switch would increase biomedical prevention coverage compared to standard-of-care (SoC) among men and women at risk for HIV in rural Uganda and Kenya. Methods: Participants were recruited from three randomized studies of the SEARCH…

ART-Free HIV-1 Remission in Very Early Treated Children: Results From IMPAACT P1115

Background: Very early initiation of antiretroviral therapy (ART) may limit the establishment of HIV-1 reservoirs in neonates, potentially enabling ART-free remission. We describe 6 children who received very early NVP- and PI-based ART and underwent analytical treatment interruption (ATI) in IMPAACT P1115 to assess for remission. Methods: Fifty-four infants with in utero HIV-1 (confirmed by…

Persistence on Contraception and PrEP in Hair Salons in South Africa

Background: Young women have high HIV incidence and risk for unintended births in sub-Saharan Africa. Women congregate regularly in hair salons; these may be useful community settings for providing HIV prevention and family planning. Our objective was to assess PrEP and contraceptive persistence following dispensing in hair salons in South Africa. Methods: We conducted a…

Cost-Effectiveness of an Agricultural Intervention Among Adults With HIV and Their Children in Kenya

Background: Agricultural interventions to address food insecurity have been shown to improve HIV health outcomes through nutritional, mental health, and health behavior pathways, but little is known about their costs and cost-effectiveness Methods: We estimated costs and incremental cost-effectiveness of implementing a multisectoral agricultural intervention (Shamba Maisha) compared to control within a cluster-randomized trial in…

Rapid Long-Acting Injectable PrEP Implementation in a Vulnerable Urban Safety Net Clinic Population

Background: Despite effective oral PrEP, barriers to uptake and adherence persist, including stigma, substance use (SU), housing/food insecurity, and mental health issues. Long-acting cabotegravir (CAB) PrEP is highly efficacious and may address barriers for patients with adherence challenges, but uptake has been low and real-world data is lacking. Methods: We describe a CAB demonstration project…